PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of emermedjEmergency Medical JournalCurrent TOCInstructions to authors
 
Emerg Med J. May 2004; 21(3): 317–322.
PMCID: PMC1726316
A combined HPLC-immunoenzymatic comprehensive screening for suspected drug poisoning in the emergency department
A Fabbri, S Ruggeri, G Marchesini, and A Vandelli
Dipartimento Emergenza-Urgenza Accettazione, Ospedale GB Morgagni, Azienda Unità Sanitaria Locale di Forlì, Italy. andfabbri@libero.it ; <andfabbri/at/libero.it>
Abstract
Objective: To review the results of a comprehensive drug screening as first line diagnostic tool in patients attending an emergency department for suspected drug poisoning.
Methods: A comprehensive drug screening was carried out in plasma or urine, or both, of 310 patients combining an HPLC multidrug profiling system and a fluorescence polarisation immunoassay.
Results: In 64.2% of cases the screening confirmed the diagnosis of drug poisoning, in 13.9% suspected drugs were measurable at non-toxic concentrations, and in 21.9% no drugs were found. The suspected drugs were fully confirmed in a minority of cases, (symptomatic patients: 28.2% compared with asymptomatic: 16.5%). Symptomatic patients were less likely to have at least one suspected drug (29.6% compared with 57.7%; p<0.001), and more likely to have at least one unsuspected drug found at analysis (17.4% compared with 3.1%; p = 0.005). In 5% of patients, asymptomatic when first observed, one or more unsuspected drugs were found. In 6 of 29 patients, with suspected poisoning of an unspecified drug, the screening identified the specific drug and excluded acute intoxication in the remaining cases.
Conclusion: A rapid comprehensive drug screening adds to the diagnosis of patients with suspected drug poisoning, identifying unsuspected drugs in symptomatic patients and excluding drugs in asymptomatic subjects.
Articles from Emergency Medicine Journal : EMJ are provided here courtesy of
BMJ Group